Campbell & Co. Investment Adviser »

Crinetics Pharmaceuticals In shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 84k 36.32
2025-03-31 $236k 7.0k 33.54
2023-09-30 $1.9M 64k 29.74
2023-06-30 $389k 22k 18.02

More positions owned by Campbell & Co. Investment Adviser

Bank of Nova Scotia/The Common Stock (BNS)
Shell Adr (SHEL)
Illinois Tool Works Common Stock (ITW)
Williams Cos Inc/The Common Stock (WMB)
Alphabet Common Stock (GOOGL)
Phillips 66 Common Stock (PSX)
Murphy Oil Corp Common Stock (MUR)
Teledyne Technologies Common Stock (TDY)
Nordson Corp Common Stock (NDSN)
Agilent Technologies Common Stock (A)
EQT Corp Common Stock (EQT)
Expand Energy Corp Common Stock (EXE)
Atmos Energy Corp Common Stock (ATO)
Chevron Corp Common Stock (CVX)
Baker Hughes Common Stock (BKR)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
BlackRock
Farallon Capital Management
Wellington Management Company
Driehaus Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Henderson Group
EcoR1 Capital
Geode Capital Management
State Street Corporation
Baker Bros. Advisors
Pictet Asset Management Holding SA
Bnp Paribas Investment Partners

View all funds holding Crinetics Pharmaceuticals In